Polypharmacy

• 

  Subject Areas on Research

  • A summary of the FDA-NIMH-MATRICS workshop on clinical trial design for neurocognitive drugs for schizophrenia. 
  • A systematic review of treatments for refractory depression in older people. 
  • Adverse drug events in high risk older outpatients. 
  • Adverse drug reaction risk factors in older outpatients. 
  • Association of Nondisease-Specific Problems with Mortality, Long-Term Care, and Functional Impairment among Older Adults Who Require Skilled Nursing Care after Dialysis Initiation. 
  • Baseline Parameters in Clinical Trials for Nonalcoholic Steatohepatitis: Recommendations From the Liver Forum. 
  • Blood Pressure, Antihypertensive Polypharmacy, Frailty, and Risk for Serious Fall Injuries Among Older Treated Adults With Hypertension. 
  • Changes in anticholinergic load from regular prescribed medications in palliative care as death approaches. 
  • Clinicians' utilization of child mental health telephone consultation in primary care: findings from Massachusetts. 
  • Combination drug therapy for Alzheimer's disease: what is evidence-based, and what is not? 
  • Common comorbidity scales were similar in their ability to predict health care costs and mortality. 
  • Descriptive analysis of concomitant prescription medication patterns from 1999 to 2004 among US women receiving daily or weekly oral bisphosphonate therapy. 
  • Drug-drug interactions in older adults: which ones matter? 
  • Effectiveness of switching from antipsychotic polypharmacy to monotherapy. 
  • Frameworks for approaching prescribing at the end of life. 
  • Impact of inappropriate drug use on mortality and functional status in representative community dwelling elders. 
  • Inappropriate drug use among community-dwelling elderly. 
  • Managing comorbidities in patients at the end of life. 
  • Medication Initiation Burden Required to Comply With Heart Failure Guideline Recommendations and Hospital Quality Measures. 
  • Nonantiretroviral polypharmacy and adverse health outcomes among HIV-infected and uninfected individuals. 
  • Outcomes of apixaban versus warfarin in patients with atrial fibrillation and multi-morbidity: Insights from the ARISTOTLE trial. 
  • Patient perspectives on having multiple versus single prescribers of chronic disease medications: results of a qualitative study in a veteran population. 
  • Physician agreement with pharmacist-suggested drug therapy changes for elderly outpatients. 
  • Polypharmacy and effects of apixaban versus warfarin in patients with atrial fibrillation: post hoc analysis of the ARISTOTLE trial. 
  • Polypharmacy and the Efficacy and Safety of Rivaroxaban Versus Warfarin in the Prevention of Stroke in Patients With Nonvalvular Atrial Fibrillation. 
  • Polypharmacy in patients with advanced cancer and the role of medication discontinuation. 
  • Polypharmacy in pregnant women with major psychiatric illness: a pilot study. 
  • Polypharmacy management in Medicare managed care: changes in prescribing by primary care physicians resulting from a program promoting medication reviews. 
  • Prescriber Continuity and Disease Control of Older Adults. 
  • Prescriber continuity and medication adherence for complex patients. 
  • Prescribing in palliative care as death approaches. 
  • Prescription of QT-prolonging drugs in a cohort of about 5 million outpatients. 
  • Psychometric Properties of the Four-Item Morisky Green Levine Medication Adherence Scale among Atherosclerosis Risk in Communities (ARIC) Study Participants. 
  • Psychotropic Polypharmacy Among Children and Youth Receiving Medicaid, 2012-2015. 
  • QT interval prolongation and torsades de pointes in a patient undergoing treatment with vorinostat: a case report and review of the literature. 
  • Quantifying the utility of taking pills for cardiovascular prevention. 
  • Randomized Controlled Trial of Screening, Risk Modification, and Physical Therapy to Prevent Falls Among the Elderly Recently Discharged From the Emergency Department to the Community: The Steps to Avoid Falls in the Elderly Study. 
  • Recent Literature Update on Medication Risk in Older Adults, 2015-2016. 
  • Reducing medication regimen complexity: a controlled trial. 
  • Response by Piccini et al to Letters Regarding Article, "Polypharmacy and the Efficacy and Safety of Rivaroxaban Versus Warfarin in the Prevention of Stroke in Patients With Nonvalvular Atrial Fibrillation". 
  • Sino-implant (II)® continuation and effect of concomitant tenofovir disoproxil fumarate-emtricitabine use on plasma levonorgestrel concentrations among women in Bondo, Kenya. 
  • The Burden of Polypharmacy in Patients Near the End of Life. 
  • Treatment considerations for elderly and frail patients with neuropathic pain. 
  • Underuse of indicated medications among physically frail older US veterans at the time of hospital discharge: results of a cross-sectional analysis of data from the Geriatric Evaluation and Management Drug Study. 
  • Unnecessary drug use in frail older people at hospital discharge. 
  • Update on Medication Use Quality and Safety in Older Adults, 2017. 
  • Usability of mobile technology to screen for drug-drug interactions in kidney transplant patients. 
  • Use of psychotropic medications by youths in therapeutic foster care and group homes. 
  • What types of inappropriate prescribing predict adverse drug reactions in older adults? 
  • Whatever happened to the polypill?